Chapter 3 70 36. van de Wal-Visscher ER, Kooman JP, van der Sande FM. Magnesium in Chronic Kidney Disease: Should We Care? Blood Purif. 2018;45(1-3):173-178. doi:10.1159/000485212 37. Barbagallo M, Gupta RK, Dominguez LJ, Resnick LM. Cellular ionic alterations with age: relation to hypertension and diabetes. J Am Geriatr Soc. 2000;48(9):1111-1116. doi:10.1111/j.1532-5415.2000.tb04788.x 38. Joosten MM, Gansevoort RT, Mukamal KJ, et al. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertens (Dallas, Tex 1979). 2013;61(6):1161-1167. doi:10.1161/HYPERTENSIONAHA.113.01333 39. Joosten MM, Gansevoort RT, Mukamal KJ, et al. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr. 2013;97(6):1299-1306. doi:10.3945/ajcn.112.054114 40. Bohn T, Walczyk T, Davidsson L, et al. Comparison of urinary monitoring, faecal monitoring and erythrocyte analysis of stable isotope labels to determine magnesium absorption in human subjects. Br J Nutr. 2004;91(1):113-120. doi:10.1079/bjn20031023
RkJQdWJsaXNoZXIy MTk4NDMw